Christopher Finnegan
About
In The Last Decade
Christopher Finnegan
22 papers receiving 459 citations
Peers
Comparison fields: 5 of 72
- Virology 176
- Pollution 136
- Health, Toxicology and Mutagenesis 93
- Infectious Diseases 73
- Public Health, Environmental and Occupational Health 72
Countries citing papers authored by Christopher Finnegan
This map shows the geographic impact of Christopher Finnegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Finnegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Finnegan more than expected).
Fields of papers citing papers by Christopher Finnegan
This network shows the impact of papers produced by Christopher Finnegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Finnegan. The network helps show where Christopher Finnegan may publish in the future.
Co-authorship network of co-authors of Christopher Finnegan
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Finnegan. A scholar is included among the top collaborators of Christopher Finnegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Finnegan. Christopher Finnegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 24 | |
| 3 | 3 | |
| 4 | 36 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 22 | |
| 9 | 98 | |
| 10 | 2 | |
| 11 | 26 | |
| 12 | 2 | |
| 13 | 8 | |
| 14 | 16 | |
| 15 | Susceptibility of Diverse HIV-1 Patient Isolates to the Maturation Inhibitor, Bevirimat (MPC-4326*), is Determined by Clade- Specific Polymorphisms in Gag CA-SP1 | 3 |
| 16 | 25 | |
| 17 | 1 | |
| 18 | 111 | |
| 19 | 43 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.